Terumo Cardiovascular Group
- OPTIMIZING CARDIAC SURGERY
- BROWSE OPTIMIZING CARDIAC SURGERY BY
- Clinical Interest »
- Cardiopulmonary Bypass »
- Endoscopic Vessel Harvesting »
- Vascular Grafting »
- Platelet Therapy »
- Product Interest »
Terumo Acquires Orpheus Simulator Technology
Terumo Cardiovascular Systems acquired the Orpheus High-Fidelity Simulator product line from Ulco Technologies, Sydney, Australia. As of February 28, 2012, Terumo CVS is the exclusive global owner of this technology and owns the manufacturing rights for the Orpheus simulator.
"The acquisition of the Orpheus technology demonstrates Terumo's continued commitment to the perfusion community and to the on-going education of perfusionists with state-of-the-art technology," says Mark Sutter, President and CEO of Terumo Cardiovascular Systems.
The Orpheus perfusion simulator is a computer controlled model of the human circulatory system intended for use in education and training for personnel involved in cardiopulmonary bypass. The simulator re-creates a variety of events which may occur during cardiopulmonary bypass. It incorporates physiological and pharmacological models and functions as a complete patient substitute for training perfusionists and other medical staff in the use of heart-lung machines and related products.
Terumo Offers Simulation Training
To demonstrate the Orpheus High-Fidelity Simulator, Terumo offered perfusionists hands-on simulation workshops at the Cardiothoracic Surgery Symposium (CREF) in San Diego in February. Two simulation workshops were conducted simultaneously during three days of the conference. Interest was high and 130 perfusionists and clinicians participated.
"The most obvious benefit of simulation training is the ability to change an oxygenator during an emergency," says David Biessenberger, CCP, Louisiana Perfusion Services, who participated in an hour-long simulation session at CREF.
This one-of-a-kind technology allows cardiac surgery professionals to practice high-risk perfusion procedures in a simulated setting without risking patient safety.
"It's critical for perfusionists to participate in simulation. It allows you to simulate emergencies in a safe environment and come up with solutions," says Deb Zarro, Senior Clinical Specialist, Terumo CVS.
Why did Terumo acquire the Orpheus technology?
This technology complements Terumo's educational goal of providing advanced training opportunities for perfusionists. Backed by Terumo's well established customer support network, Terumo will make the Orpheus simulator technology available to clinical professionals throughout the world.